INO-3107 – Patient Worthy

source: pixabay.com

First Patient Dosed in Recurrent Respiratory Papillomatosis Trial

Post author:James Moore
Post published:December 3, 2020
Post category:Recurrent respiratory papillomatosis

According to a press release from Inovio Pharmaceuticals, the biotechnology company has officially dosed the first patient in its phase 1/2 clinical trial, which will test the company's investigational therapeutic…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More